Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e30.

Effect of Vitamin D in Experimental Pulmonary Arterial Hypertension in Rats: Possible Role of eNOS-mediated Signalling Pathways

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e28.

HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e27.

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e23.